Santhera Pharmaceuticals AG (SPHDF) on Monday said the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended expanding the use of AGAMREE to treat children as young as two years old with Duchenne muscular dystrophy.
AGAMREE is currently approved in the European Union for patients aged four and older.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.